Spruce Biosciences, Inc.
SPRB
$0.0947
-$0.0351-27.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.56M | -8.67M | -9.18M | -11.63M | -9.95M |
| Total Depreciation and Amortization | 9.00K | 10.00K | 12.00K | 15.00K | 16.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.03M | 1.20M | 1.75M | 1.62M | 1.21M |
| Change in Net Operating Assets | 1.85M | -1.76M | -3.69M | -4.97M | -2.49M |
| Cash from Operations | -20.68M | -9.22M | -11.11M | -14.96M | -11.21M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 9.30M |
| Cash from Investing | -- | -- | -- | -- | 9.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -406.00K | -405.00K | -406.00K | -405.00K | -406.00K |
| Issuance of Common Stock | 14.00K | 0.00 | 52.00K | 180.00K | 71.00K |
| Repurchase of Common Stock | -233.00K | 0.00 | -11.00K | -2.00K | -217.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -625.00K | -405.00K | -365.00K | -227.00K | -552.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.30M | -9.63M | -11.47M | -15.19M | -2.46M |